4.64 USD
-0.09 (-1.9%)
4.69 USD
+0.05 (+1.08%)
We assign a fundamental rating of 4 out of 10 to ALVO. ALVO was compared to 530 industry peers in the Biotechnology industry. There are concerns on the financial health of ALVO while its profitability can be described as average. ALVO is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year ALVO was profitable.
In the past year ALVO has reported a negative cash flow from operations.
In the past 5 years ALVO always reported negative net income.
ALVO had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.93%, ALVO belongs to the top of the industry, outperforming 91.13% of the companies in the same industry.
ALVO's Return On Invested Capital of 3.10% is amongst the best of the industry. ALVO outperforms 90.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.93% | ||
| ROE | N/A | ||
| ROIC | 3.1% |
ROA(3y)-46.35%
ROA(5y)-38.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of ALVO (12.12%) is better than 91.89% of its industry peers.
The Operating Margin of ALVO (7.57%) is better than 90.19% of its industry peers.
ALVO's Gross Margin of 55.59% is fine compared to the rest of the industry. ALVO outperforms 77.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.57% | ||
| PM (TTM) | 12.12% | ||
| GM | 55.59% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ALVO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ALVO has been increased compared to 1 year ago.
ALVO has a better debt/assets ratio than last year.
2.2 Solvency
ALVO has an Altman-Z score of -1.09. This is a bad value and indicates that ALVO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALVO (-1.09) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.09 |
ROIC/WACC0.5
WACC6.26%
2.3 Liquidity
ALVO has a Current Ratio of 1.42. This is a normal value and indicates that ALVO is financially healthy and should not expect problems in meeting its short term obligations.
ALVO's Current ratio of 1.42 is on the low side compared to the rest of the industry. ALVO is outperformed by 81.32% of its industry peers.
ALVO has a Quick Ratio of 1.42. This is a bad value and indicates that ALVO is not financially healthy enough and could expect problems in meeting its short term obligations.
ALVO has a worse Quick ratio (0.74) than 87.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
ALVO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 122.99%, which is quite impressive.
Looking at the last year, ALVO shows a very strong growth in Revenue. The Revenue has grown by 426.84%.
The Revenue has been growing by 42.86% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)122.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)426.84%
Revenue growth 3Y131.44%
Revenue growth 5Y42.86%
Sales Q2Q%0%
3.2 Future
The Earnings Per Share is expected to grow by 41.54% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 33.06% on average over the next years. This is a very strong growth
EPS Next Y116.02%
EPS Next 2Y57.41%
EPS Next 3Y41.54%
EPS Next 5YN/A
Revenue Next Year28.26%
Revenue Next 2Y36.14%
Revenue Next 3Y33.06%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
ALVO is valuated rather expensively with a Price/Earnings ratio of 23.20.
Based on the Price/Earnings ratio, ALVO is valued cheaply inside the industry as 94.15% of the companies are valued more expensively.
ALVO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
ALVO is valuated reasonably with a Price/Forward Earnings ratio of 11.16.
ALVO's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALVO is cheaper than 98.11% of the companies in the same industry.
ALVO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.2 | ||
| Fwd PE | 11.16 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ALVO is valued cheaply inside the industry as 92.26% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 34.34 |
4.3 Compensation for Growth
ALVO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALVO's earnings are expected to grow with 41.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y57.41%
EPS Next 3Y41.54%
5. Dividend
5.1 Amount
No dividends for ALVO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
4.64
-0.09 (-1.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners5.46%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap1.45B
Revenue(TTM)491.98M
Net Income(TTM)69.50M
Analysts81.82
Price Target8.93 (92.46%)
Short Float %1.6%
Short Ratio2.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)206.21%
Min EPS beat(2)-145.1%
Max EPS beat(2)557.52%
EPS beat(4)3
Avg EPS beat(4)215.83%
Min EPS beat(4)-145.1%
Max EPS beat(4)557.52%
EPS beat(8)5
Avg EPS beat(8)737.22%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)18.13%
Min Revenue beat(2)-4.76%
Max Revenue beat(2)41.02%
Revenue beat(4)3
Avg Revenue beat(4)25.91%
Min Revenue beat(4)-4.76%
Max Revenue beat(4)41.02%
Revenue beat(8)4
Avg Revenue beat(8)9.39%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-19.72%
PT rev (3m)-50%
EPS NQ rev (1m)65.38%
EPS NQ rev (3m)-163.38%
EPS NY rev (1m)-43.05%
EPS NY rev (3m)-39.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-11.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.2 | ||
| Fwd PE | 11.16 | ||
| P/S | 2.52 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 34.34 |
EPS(TTM)0.2
EY4.31%
EPS(NY)0.42
Fwd EY8.96%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS1.84
BVpS-0.57
TBVpS-0.81
PEG (NY)0.2
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.93% | ||
| ROE | N/A | ||
| ROCE | 3.93% | ||
| ROIC | 3.1% | ||
| ROICexc | 3.23% | ||
| ROICexgc | 3.47% | ||
| OM | 7.57% | ||
| PM (TTM) | 12.12% | ||
| GM | 55.59% | ||
| FCFM | N/A |
ROA(3y)-46.35%
ROA(5y)-38.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 15.52 | ||
| Cap/Depr | 313.02% | ||
| Cap/Sales | 19.43% | ||
| Interest Coverage | 1.69 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | -1.09 |
F-Score4
WACC6.26%
ROIC/WACC0.5
Cap/Depr(3y)204.72%
Cap/Depr(5y)182.09%
Cap/Sales(3y)39.66%
Cap/Sales(5y)47.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y116.02%
EPS Next 2Y57.41%
EPS Next 3Y41.54%
EPS Next 5YN/A
Revenue 1Y (TTM)426.84%
Revenue growth 3Y131.44%
Revenue growth 5Y42.86%
Sales Q2Q%0%
Revenue Next Year28.26%
Revenue Next 2Y36.14%
Revenue Next 3Y33.06%
Revenue Next 5YN/A
EBIT growth 1Y306.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year53.05%
EBIT Next 3Y67.64%
EBIT Next 5YN/A
FCF growth 1Y61.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.44%
OCF growth 3YN/A
OCF growth 5YN/A
ALVOTECH SA / ALVO FAQ
What is the ChartMill fundamental rating of ALVOTECH SA (ALVO) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ALVO.
What is the valuation status of ALVOTECH SA (ALVO) stock?
ChartMill assigns a valuation rating of 6 / 10 to ALVOTECH SA (ALVO). This can be considered as Fairly Valued.
Can you provide the profitability details for ALVOTECH SA?
ALVOTECH SA (ALVO) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for ALVO stock?
The Earnings per Share (EPS) of ALVOTECH SA (ALVO) is expected to grow by 116.02% in the next year.